Transcriptional mechanisms of lithium action: Therapeutic implications

Clinical Neuroscience Research

Volumn 4, Issue 3-4 SPEC. ISS., 2004, Pages 271-280

  Li, Peter P ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bipolar disorder; Differential display; Gene expression; Lithium; Microarray; Neuroplasticity; Transcription factors

Indexed keywords

ARACHIDONIC ACID; COMPLEMENTARY DNA; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYSTEINE STRING PROTEIN; INOSITOL PHOSPHATE; LITHIUM SALT; MARCKS PROTEIN; MYOINOSITOL 1 PHOSPHATE SYNTHASE; NEUROPEPTIDE; OMEGA 3 FATTY ACID; PHOSPHATIDYLINOSITOL; PROTEIN BAX; PROTEIN BCL 2; SECRETOGRANIN II; SYNAPSIN; SYNAPTOBREVIN; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR AP 1; VESICULAR ACETYLCHOLINE TRANSPORTER; VESICULAR MONOAMINE TRANSPORTER 1;

BIPOLAR DISORDER; CELL SURVIVAL; DNA MICROARRAY; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION REGULATION; HUMAN; LATENT PERIOD; MYELINATION; NERVE CELL DIFFERENTIATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; TRANSCRIPTION REGULATION;

EID: 13344287028     PISSN: 15662772     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cnr.2004.09.005     Document Type: Review

References (95)

1. M. Schou Lithium treatment at 52 J Affect Disord 67 2001 21-32
2. S.E. Hyman E.J. Nestler Initiation and adaptation: A paradigm for understanding psychotropic drug action Am J Psychiatry 153 2 1996 151-162
3. R.S. Jope Anti-bipolar therapy: Mechanism of action of lithium Mol Psychiatry 4 2 1999 117-128
4. H.K. Manji R.H. Lenox Protein kinase C signaling in the brain: Molecular transduction of mood stabilization in the treatment of manic-depressive illness Biol Psychiatry 46 10 1999 1328-1351
5. P.P. Li S. Andreopoulos J.J. Warsh Signal transduction abnormalities in bipolar affective disorder In: M.E.A. Reith editor Cerebral signal transduction: From first to fourth messenger 2000 Humana Press 283-309
6. J.I. Morgan T. Curran Stimulus-transcription coupling in the nervous system: Involvement of the inducible proto-oncogenes fos and jun Annu Rev Neurosci 14 1991 421-451
7. T. Curran B.R. Franza Jr Fos and Jun: The AP-1 connection Cell 55 3 1988 395-397
8. G.A. Gonzalez M.R. Montminy Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133 Cell 59 4 1989 675-680
9. A.E. West W.G. Chen M.B. Dalva R.E. Dolmetsch J.M. Kornhauser A.J. Shaywitz et al. Calcium regulation of neuronal gene expression Proc Natl Acad Sci USA 98 20 2001 11024-11031
10. N. Ozaki D.M. Chuang Lithium increases transcription factor binding to AP-1 and cyclic AMP-responsive element in cultured neurons and rat brain J Neurochem 69 6 1997 2336-2344
11. J.F. Wang V. Asghari C. Rockel L.T. Young Cyclic AMP responsive element binding protein phosphorylation and DNA binding is decreased by chronic lithium but not valproate treatment of SH-SY5Y neuroblastoma cells Neuroscience 91 2 1999 771-776
12. P.X. Yuan G. Chen L.D. Huang H.K. Manji Lithium stimulates gene expression through the AP-1 transcription factor pathway Brain Res Mol Brain Res 58 1-2 1998 225-230
13. P. Yuan G. Chen H.K. Manji Lithium activates the c-Jun NH2-terminal kinases in vitro and in the CNS in vivo J Neurochem 73 6 1999 2299-2309
14. M.T. Unlap R.S. Jope Lithium attenuates nerve growth factor-induced activation of AP-1 DNA binding activity in PC12 cells Neuropsychopharmacology 17 1 1997 12-17
15. M.A. Pacheco R.S. Jope Modulation of carbachol-stimulated AP-1 DNA binding activity by therapeutic agents for bipolar disorder in human neuroblastoma SH-SY5Y cells Brain Res Mol Brain Res 72 2 1999 138-146
16. R.S. Jope A bimodal model of the mechanism of action of lithium Mol Psychiatry 4 1 1999 21-25
17. S. Mori D. Tardito A. Dorigo R. Zanardi E. Smeraldi G. Racagni J. Perez Effects of lithium on cAMP-dependent protein kinase in rat brain Neuropsychopharmacology 19 3 1998 233-240
18. H.K. Manji R.H. Lenox Long-term action of lithium: A role for transcriptional and posttranscriptional factors regulated by protein kinase C Synapse 16 1 1994 11-28
19. H. Einat P. Yuan T.D. Gould J. Li J. Du L. Zhang et al. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation J Neurosci 23 19 2003 7311-7316
20. R. Pardo A.G. Andreolotti B. Ramos F. Picatoste E. Claro Opposed effects of lithium on the MEK-ERK pathway in neural cells: Inhibition in astrocytes and stimulation in neurons by GSK3 independent mechanisms J Neurochem 87 2 2003 417-426
21. C.A. Grimes R.S. Jope The multifaceted roles of glycogen synthase kinase 3β in cellular signaling Prog Neurobiol 65 4 2001 391-426
22. L. Wang X. Liu R.H. Lenox Transcriptional down-regulation of MARCKS gene expression in immortalized hippocampal cells by lithium J Neurochem 79 4 2001 816-825
23. G. Chen W.Z. Zeng P.X. Yuan L.D. Huang Y.M. Jiang Z.H. Zhao H.K. Manji The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS J Neurochem 72 2 1999 879-882
24. E. Bettini E. Magnani G.C. Terstappen Lithium induces gene expression through lymphoid enhancer-binding factor/T-cell factor responsive element in rat PC12 cells Neurosci Lett 317 1 2002 50-52
25. J.C. Bournat A.M. Brown A.P. Soler Wnt-1 dependent activation of the survival factor NF-κB in PC12 cells J Neurosci Res 61 1 2000 21-32
26. M. Karin T. Smeal Control of transcription factors by signal transduction pathways: The beginning of the end Trends Biochem Sci 17 10 1992 418-422
27. H.K. Manji R.H. Lenox Signaling: Cellular insights into the pathophysiology of bipolar disorder Biol Psychiatry 48 6 2000 518-530
28. i-protein α subunit in rat cerebral cortex Proc Natl Acad Sci USA 88 23 1991 10634-10637
29. P.P. Li L.T. Young Y.K. Tam D. Sibony J.J. Warsh Effects of chronic lithium and carbamazepine treatment on G-protein subunit expression in rat cerebral cortex Biol Psychiatry 34 3 1993 162-170
30. F. Karege C. Buresi J. Golaz M. Schwald A. Malafosse Decreased expression of Galphas mRNA and protein levels in lithium-treated bipolar affective disorder Hum Psychopharmacol 15 3 2000 191-197
31. J.B. Jensen J.D. Mikkelsen A. Mork Increased adenylyl cyclase type 1 mRNA, but not adenylyl cyclase type 2 in the rat hippocampus following antidepressant treatment Eur Neuropsychopharmacol 10 2 2000 105-111
32. M.E. Newman R.H. Belmaker Effects of lithium in vitro and ex vivo on components of the adenylate cyclase system in membranes from the cerebral cortex of the rat Neuropharmacology 26 2-3 1987 211-217
33. M.I. Masana J.A. Bitran J.K. Hsiao I.N. Mefford W.Z. Potter Lithium effects on noradrenergic-linked adenylate cyclase activity in intact rat brain: An in vivo microdialysis study Brain Res 538 2 1991 333-336
34. sα protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder J Neurochem 61 3 1993 890-898
35. X. Sun L.T. Young J.F. Wang P. Grof G. Turecki G.A. Rouleau M. Alda Identification of lithium-regulated genes in cultured lymphoblasts of lithium responsive subjects with bipolar disorder Neuropsychopharmacology 2004
36. L.M. Hallcher W.R. Sherman The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain J Biol Chem 255 22 1980 10896-10901
37. M.J. Berridge C.P. Downes M.R. Hanley Neural and developmental actions of lithium: A unifying hypothesis Cell 59 3 1989 411-419
38. P.F. Renshaw N.E. Joseph J.S. Leigh Jr Chronic dietary lithium induces increased levels of myo-inositol-1-phosphatase activity in rat cerebral cortex homogenates Brain Res 380 2 1986 401-404
39. L.K. Parthasarathy R.S. Seelan M.A. Wilson R.E. Vadnal R.N. Parthasarathy Regional changes in rat brain inositol monophosphatase 1 (IMPase 1) activity with chronic lithium treatment Prog Neuropsychopharmacol Biol Psychiatry 27 1 2003 55-60
40. G. Sjoholt A. Molven R. Lovlie A. Wilcox J.M. Sikela V.M. Steen Genomic structure and chromosomal localization of a human myo-inositol monophosphatase gene (IMPA) Genomics 45 1 1997 113-122
41. G. Sjoholt A.K. Gulbrandsen R. Lovlie J.O. Berle A. Molven V.M. Steen A human myo-inositol monophosphatase gene (IMPA2) localized in a putative susceptibility region for bipolar disorder on chromosome 18p11.2: genomic structure and polymorphism screening in manic-depressive patients Mol Psychiatry 5 2 2000 172-180
42. W.H. Berrettini Genetics of psychiatric disease Annu Rev Med 51 2000 465-479
43. A. Shamir G. Shaltiel M.L. Greenberg R.H. Belmaker G. Agam The effect of lithium on expression of genes for inositol biosynthetic enzymes in mouse hippocampus; a comparison with the yeast model Mol Brain Res 115 2 2003 104-110
44. A. Shamir R.P. Ebstein L. Nemanov A. Zohar R.H. Belmaker G. Agam Inositol monophosphatase in immortalized lymphoblastoid cell lines indicates susceptibility to bipolar disorder and response to lithium therapy Mol Psychiatry 3 6 1998 481-482
45. I.S. Yoon P.P. Li K.P. Siu J.L. Kennedy R.G. Cooke S.V. Parikh J.J. Warsh Altered IMPA2 gene expression and calcium homeostasis in bipolar disorder Mol Psychiatry 6 6 2001 678-683
46. B. Lubrich D. van Calker Inhibition of the high affinity myo-inositol transport system: A common mechanism of action of antibipolar drugs? Neuropsychopharmacology 21 4 1999 519-529
47. R.H. Lenox L. Wang Molecular basis of lithium action: Integration of lithium-responsive signaling and gene expression networks Mol Psychiatry 8 2 2003 135-144
48. L.V. Hua M. Green J.J. Warsh P.P. Li Molecular cloning of a novel isoform of diphosphoinositol polyphosphate phosphohydrolase: A potential target of lithium therapy Neuropsychopharmacology 24 6 2001 640-651
49. J.J. Caffrey S.T. Safrany X. Yang S.B. Shears Discovery of molecular and catalytic diversity among human diphosphoinositol-polyphosphate phosphohydrolases. An expanding Nudt family J Biol Chem 275 17 2000 12730-12736
50. R.S. Williams M. Eames W.J. Ryves J. Viggars A.J. Harwood Loss of a prolyl oligopeptidase confers resistance to lithium by elevation of inositol (1,4,5) trisphosphate Eur Mol Biol Org J 18 10 1999 2734-2745
51. L.V. Hua M. Green J.J. Warsh P.P. Li Lithium regulation of aldolase A expression in the rat frontal cortex: Identification by differential display Biol Psychiatry 48 1 2000 58-64
52. Hua LV. Identification and characterization of differentially expressed genes following chronic lithium treatment in rat brain. PhD thesis, University of Toronto; 2001.
53. H. Meltzer Creatine kinase and aldolase in serum: Abnormality common to acute psychoses Science 159 821 1968 1368-1370
54. N.L. Johnston-Wilson C.D. Sims J.P. Hofmann et al. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium Mol Psychiatry 5 2 2000 142-149
55. L.V. Hua M. Green A. Wong J.J. Warsh P.P. Li Tetraspan protein CD151: A common target of mood stabilizing drugs? Neuropsychopharmacology 25 5 2001 729-736
56. M.E. Hemler Integrin associated proteins Curr Opin Cell Biol 10 5 1998 578-585
57. E. Friedman W. Hoau Yan D. Levinson T.A. Connell H. Singh Altered platelet protein kinase C activity in bipolar affective disorder, manic episode Biol Psychiatry 33 7 1993 520-525
58. J.C. Soares A.G. Mallinger C.S. Dippold K. Forster Wells E. Frank D.J. Kupfer Effects of lithium on platelet membrane phosphoinositides in bipolar disorder patients: A pilot study Psychopharmacology (Berl) 149 1 2000 12-16
59. J.C. Soares G. Chen C.S. Dippold K.F. Wells E. Frank D.J. Kupfer et al. Concurrent measures of protein kinase C and phosphoinositides in lithium-treated bipolar patients and healthy individuals: A preliminary study Psychiatry Res 95 2 2000 109-118
60. D.F. Horrobin C.N. Bennett Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis Possible candidate genes Prostaglandins, Leukotrienes Essential Fatty Acids 60 4 1999 217-234
61. A.L. Stoll W.E. Severus M.P. Freeman S. Rueter H.A. Zboyan E. Diamond et al. Omega 3 fatty acids in bipolar disorder: A preliminary double-blind, placebo-controlled trial Arch Gen Psychiatry 56 5 1999 407-412
62. S.I. Rapoport F. Bosetti Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder? Arch Gen Psychiatry 59 7 2002 592-596
63. H.K. Manji G.J. Moore G. Chen Lithium at 50: Have the neuroprotective effects of this unique cation been overlooked? Biol Psychiatry 46 7 1999 929-940
64. D.M. Chuang R.W. Chen E. Chalecka-Franaszek M. Ren R. Hashimoto V. Senatorov et al. Neuroprotective effects of lithium in cultured cells and animal models of diseases Bipolar Disord 4 2 2002 129-136
65. X. Li G.N. Bijur R.S. Jope Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection Bipolar Disord 4 2 2002 137-144
66. J.M. Adams Ways of dying: Multiple pathways to apoptosis Genes Dev 17 20 2003 2481-2495
67. M. Mihara S. Erster A. Zaika O. Petrenko T. Chittenden P. Pancoska U.M. Moll p53 has a direct apoptogenic role at the mitochondria Mol Cell 11 3 2003 577-590
68. R.W. Chen D.M. Chuang Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity J Biol Chem 274 10 1999 6039-6042
69. G. Rajkowska Cell pathology in bipolar disorder Bipolar Disord 4 2 2002 105-116
70. L.F. Jarskog E.S. Selinger J.A. Lieberman J.H. Gilmore Apoptotic proteins in the temporal cortex in schizophrenia: High Bax/Bcl-2 ratio without caspase-3 activation Am J Psychiatry 161 1 2004 109-115
71. T.W. Corson K.K. Woo P.P. Li J.J. Warsh Cell-type specific regulation of calreticulin and Bcl-2 expression by mood stabilizer drugs Eur Neuropsychopharmacol 14 2 2004 143-150
72. M.L. Cordeiro J.A. Umbach C.B. Gundersen Lithium ions up-regulate mRNAs encoding dense-core vesicle proteins in nerve growth factor-differentiated PC12 cells J Neurochem 75 6 2000 2622-2625
73. M.L. Cordeiro J.A. Umbach C.B. Gundersen Lithium ions enhance cysteine string protein gene expression in vivo and in vitro J Neurochem 74 6 2000 2365-2372
74. M.L. Cordeiro C.B. Gundersen J.A. Umbach Convergent effects of lithium and valproate on the expression of proteins associated with large dense core vesicles in NGF-differentiated PC12 cells Neuropsychopharmacology 29 2004 39-44
75. S.L. Treiser C.S. Cascio T.L. O'Donohue N.B. Thoa D.M. Jacobowitz K.J. Kellar Lithium increases serotonin release and decreases serotonin receptors in the hippocampus Science 213 4515 1981 1529-1531
76. R.P. Ebstein B. Lerer M. Shlaufman R.H. Belmaker The effect of repeated electroconvulsive shock treatment and chronic lithium feeding on the release of norepinephrine from rat cortical vesicular preparations Cell Mol Neurobiol 3 3 1983 191-201
77. H. Husum J.D. Mikkelsen S. Hogg A.A. Mathe A. Mork Involvement of hippocampal neuropeptide Y in mediating the chronic actions of lithium, electroconvulsive stimulation and citalopram Neuropharmacology 39 8 2000 1463-1473
78. J.F. Wang L.T. Young Differential display PCR reveals increased expression of 2′,3′-cyclic nucleotide 3′-phosphodiesterase by lithium Fed Eur Biochem Soc Lett 386 2-3 1996 225-229
79. D. Tkachev M.L. Mimmack M.M. Ryan M. Wayland T. Freeman P.B. Jones et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder Lancet 362 9386 2003 798-805
80. W.M. McDonald L.A. Tupler F.A. Marsteller G.S. Figiel S. DiSouza C.B. Nemeroff K.R. Krishnan Hyperintense lesions on magnetic resonance images in bipolar disorder Biol Psychiatry 45 8 1999 965-971
81. M. Dziedzicka-Wasylewska K. Wedzony The effect of prolonged administration of lithium on the level of dopamine D2 receptor mRNA in the rat striatum and nucleus accumbens Acta Neurobiol Exp (Wars) 56 1 1996 29-34
82. X.M. Gao F. Fukamauchi D.M. Chuang Long-term biphasic effects of lithium treatment on phospholipase C-coupled M3-muscarinic acetylcholine receptors in cultured cerebellar granule cells Neurochem Int 22 4 1993 395-403
83. C.G. Hahn A.C. Pawlyk P.C. Whybrow L. Gyulai S.M. Tejani-Butt Lithium administration affects gene expression of thyroid hormone receptors in rat brain Life Sci 64 20 1999 1793-1802
84. M.P. Vawter W.J. Freed J.E. Kleinman Neuropathology of bipolar disorder Biol Psychiatry 48 6 2000 486-504
85. M.L. Gilmor K.H. Skelton C.B. Nemeroff M.J. Owens The effects of chronic treatment with the mood stabilizers valproic acid and lithium on corticotropin-releasing factor neuronal systems J Pharmacol Exp Ther 305 2 2003 434-439
86. O. Zachrisson A.A. Mathe C. Stenfors N. Lindefors Region-specific effects of chronic lithium administration on neuropeptide Y and somatostatin mRNA expression in the rat brain Neurosci Lett 194 1-2 1995 89-92
87. S.P. Sivam K. Takeuchi S. Li J. Douglass O. Civelli L. Calvetta et al. Lithium increases dynorphin A(1-8) and prodynorphin mRNA levels in the basal ganglia of rats Brain Res 427 2 1988 155-163
88. S.P. Sivam J.E. Krause K. Takeuchi S. Li J.F. McGinty J.S. Hong Lithium increases rat striatal beta- and gamma-preprotachykinin messenger RNAs J Pharmacol Exp Ther 248 3 1989 1297-1301
89. H. Anai Y. Ueta R. Serino M. Nomura N. Kabashima I. Shibuya et al. Upregulation of the expression of vasopressin gene in the paraventricular and supraoptic nuclei of the lithium-induced diabetes insipidus rat Brain Res 772 1-2 1997 161-166
90. L. Caberlotto Y.L. Hurd Reduced neuropeptide Y mRNA expression in the prefrontal cortex of subjects with bipolar disorder NeuroReport 10 8 1999 1747-1750
91. F. Bosetti R. Seemann J.M. Bell R. Zahorchak E. Friedman S.I. Rapoport P. Manickam Analysis of gene expression with cDNA microarrays in rat brain after 7 and 42 days of oral lithium administration Brain Res Bull 57 2 2002 205-209
92. M. Emamghoreishi L. Schlichter P.P. Li S. Parikh J. Sen A. Kamble J.J. Warsh High intracellular calcium concentrations in transformed lymphoblasts from subjects with bipolar I disorder Am J Psychiatry 154 7 1997 976-982
93. I.S. Yoon P.P. Li K.P. Siu J.L. Kennedy F. Macciardi R.G. Cooke et al. Altered TRPC7 gene expression in bipolar-I disorder Biol Psychiatry 50 8 2001 620-626
94. F. Presse B. Cardona L. Borsu J.L. Nahon Lithium increases melanin-concentrating hormone mRNA stability and inhibits tyrosine hydroxylase gene expression in PC12 cells Brain Res Mol Brain Res 52 2 1997 270-283
95. G. Chen L.D. Huang W.Z. Zeng H.K. Manji Mood stabilizers regulate cytoprotective and mRNA-binding proteins in the brain: Long-term effects on cell survival and transcript stability Int J Neuropsychopharmacol 4 1 2001 47-64